Copyright
©The Author(s) 2018.
World J Hepatol. Sep 27, 2018; 10(9): 585-594
Published online Sep 27, 2018. doi: 10.4254/wjh.v10.i9.585
Published online Sep 27, 2018. doi: 10.4254/wjh.v10.i9.585
Figure 2 Treatment of acute and chronic hepatitis B in pregnancy.
The column marked by the red circle refers to interventions that are not allowed. The column marked by the yellow circle refers to interventions that are backed up by low-quality or conflicting evidence. The column marked by the green circle refers to the best practice according to current evidence. IFN: Interferon; NA: Nucleos(t)ide analogue; LAM: Lamivudine; TDF: Tenofovir disoproxil fumarate.
- Citation: Maraolo AE, Gentile I, Buonomo AR, Pinchera B, Borgia G. Current evidence on the management of hepatitis B in pregnancy. World J Hepatol 2018; 10(9): 585-594
- URL: https://www.wjgnet.com/1948-5182/full/v10/i9/585.htm
- DOI: https://dx.doi.org/10.4254/wjh.v10.i9.585